π-Stacking Interactions Involved in Gynecologic Tankyrase-1/Inhibitor Recognition and Association: Implications for Rational Design of Aromatic Pentapeptide Ligands
{"title":"π-Stacking Interactions Involved in Gynecologic Tankyrase-1/Inhibitor Recognition and Association: Implications for Rational Design of Aromatic Pentapeptide Ligands","authors":"Yu Du, Lin Xu","doi":"10.1007/s10989-024-10596-9","DOIUrl":null,"url":null,"abstract":"<p>Human tankyrase-1 is an important regulator of poly(ADP-ribosyl)ation (PARylation) of Wnt/β-catenin signaling and has been recognized as a druggable target of gynecologic tumors. The active site of tankyrase-1 is rich with <i>π</i>-electron, which contains a number of aromatic amino aid residues and can form multiple π-stacking interactions with its substrates and ligands. In this study, computational analysis revealed that aromatic residues involved in tankyrase-1’s active site are significantly responsible for the intermolecular interaction between tankyrase-1 and its inhibitor ligands. Based on the harvested information, structure-based molecular design of aromatic pentapeptide inhibitors was carried out to target tankyrase-1. The pentapeptide candidates were defined by aromatic amino acids, and their π-stacking contribution is stronger than small-molecule inhibitors. Eight pentapeptide hits were determined to have moderate or high inhibitory potency against human tankyrase-1, in which two hits FYWYH and YWFYH can inhibit the enzyme potently at sub-micromolar level. Structural analysis observed a number of face-to-face, parallel-displaced and T-shaped π-stacking interactions at tankyrase-1/pentapeptide complex interface, which co-define a complicated π-stacking network and confer both stability and specificity for the complex formation.\n</p>","PeriodicalId":14217,"journal":{"name":"International Journal of Peptide Research and Therapeutics","volume":"90 1","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Peptide Research and Therapeutics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s10989-024-10596-9","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Human tankyrase-1 is an important regulator of poly(ADP-ribosyl)ation (PARylation) of Wnt/β-catenin signaling and has been recognized as a druggable target of gynecologic tumors. The active site of tankyrase-1 is rich with π-electron, which contains a number of aromatic amino aid residues and can form multiple π-stacking interactions with its substrates and ligands. In this study, computational analysis revealed that aromatic residues involved in tankyrase-1’s active site are significantly responsible for the intermolecular interaction between tankyrase-1 and its inhibitor ligands. Based on the harvested information, structure-based molecular design of aromatic pentapeptide inhibitors was carried out to target tankyrase-1. The pentapeptide candidates were defined by aromatic amino acids, and their π-stacking contribution is stronger than small-molecule inhibitors. Eight pentapeptide hits were determined to have moderate or high inhibitory potency against human tankyrase-1, in which two hits FYWYH and YWFYH can inhibit the enzyme potently at sub-micromolar level. Structural analysis observed a number of face-to-face, parallel-displaced and T-shaped π-stacking interactions at tankyrase-1/pentapeptide complex interface, which co-define a complicated π-stacking network and confer both stability and specificity for the complex formation.
期刊介绍:
The International Journal for Peptide Research & Therapeutics is an international, peer-reviewed journal focusing on issues, research, and integration of knowledge on the latest developments in peptide therapeutics. The Journal brings together in a single source the most exciting work in peptide research, including isolation, structural characterization, synthesis and biological activity of peptides, and thereby aids in the development of unifying concepts from diverse perspectives. The Journal invites substantial contributions in the following thematic areas:
-New advances in peptide drug delivery systems.
-Application of peptide therapeutics to specific diseases.
-New advances in synthetic methods.
-The development of new procedures for construction of peptide libraries and methodology for screening of such mixtures.
-The use of peptides in the study of enzyme specificity and mechanism, receptor binding and antibody/antigen interactions
-Applications of such techniques as chromatography, electrophoresis, NMR and X-ray crystallography, mass spectrometry.